Vical Inc. | Key People and Executives
Vijay B. Samant
President, Chief Executive Officer & Director
R. Gordon Douglas
Chairman
Thomas E. Shenk
Independent Director
George J. Morrow
Independent Director
Robert C. Merton
Independent Director
Richard M. Beleson
Independent Director
Gary A. Lyons
Independent Director
Vijay B. Samant
President, Chief Executive Officer & Director
Keith D. Hall
Vice President-Operations
Anthony Alan Ramos
Chief Financial & Accounting Officer
Lawrence Russell Smith
Senior Vice President-Research
Mammen P. Mammen
Senior Vice President-Clinical Development
Andrew Hopkins
Head-Investor Relations
R. Gordon Douglas
Chairman
Thomas E. Shenk
Independent Director
George J. Morrow
Independent Director
Robert C. Merton
Independent Director
Richard M. Beleson
Independent Director
Gary A. Lyons
Independent Director
| Address |
10390 Pacific Center Court
San Diego California 92121
United States
|
|
Employees
|
- |
| Website |
http://www.vical.com |
| Updated |
07/08/2019 |
| Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. It has active development programs which comprises of ongoing phase 2 trial of HSV-2 therapeutic vaccine, VCL-HB01, to treat patients with symptomatic genital herpes infection; ongoing phase 2 trial of novel antifungal VL-2397, for the treatment of patients with invasive aspergillosis; and early stage development program of a novel treatment for chronic hepatitis B virus (CHB) infection based on its DNA and lipid-delivery technologies. The company was founded by Howard E. |
